Novartis reported 3.32B in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Alcon AG ALC:SW 303M 148M
Amgen AMGN:US $ 2176M 324M
Artemis Alpha ATS:LN -10207000 58.81M
AstraZeneca AZN:LN 2.2B 673M
Bayer BAYN:GR 2.28B 1.89B
Biogen BIIB:US $ 940.9M 409.4M
Bristol Myers Squibb BMY:US $ 3197M 9M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Fresenius FRE:GR 698M 105M
Fresenius Medical Care FME:GR 322M 111.18M
Galapagos GLPG:NA -76332000 55.19M
Genmab GEN:DC 514M 295M
Gilead Sciences GILD:US $ 2029M 868M
GlaxoSmithKline GSK:LN 1.82B 600M
Hikma Pharmaceutical HIK:LN 256M 23M
Johnson & Johnson JNJ:US $ 6941M 599M
Lonza Group LONN:SW 667M 116M
Merck MRK:GR 1.35B 146M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Novartis NVS:US 3.32B 176M
Orion ORNBV:FH 82M 10.5M
Pfizer PFE:US $ 12099M 2104M
Philips PHIA:NA 135M 108M
Recordati REC:IM 122.46M 15.94M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M